Menu
Not yet recruiting NCT06390527

Ultrasonography in Diagnosis of Polyneuropathy

— Observational Polyneuropathies

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Polyneuropathies. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Optimization of Ultrasound Sheer Wave Elastography for the Evaluation of Peripheral Nerve Disorders

Overview

The main goal of this trial is to establish recommendations for clinical practice that enhance the reliability, accessibility and convenience of sheer wave elastography as a routine diagnostic test for diverse peripheral neuropathies.

Primary outcome measures

  • Clinical examination [Time frame: Through study completion, an average 2 years.]
  • Electrodiagnostic studies [Time frame: Through study completion, an average 2 years.]
  • Ultrasonography [Time frame: Through study completion, an average 2 years.]
  • Patient history [Time frame: Through study completion, an average 2 years.]

Eligibility criteria

Inclusion criteria

  • Age 18-80 years
  • Clinical signs of particular polyneuropathy not explained by other causes

Exclusion criteria

  • Entrapment or compression neuropathies
  • Nerve trauma
  • The diagnosis of vasculitic neuropathy, neuralgic amyotrophy, diabetic radiculo-plexo-neuropathy, hereditary neuropathy with liability to pressure palsies and motor neuron disorders including monomelic amyotrophy.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-control

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06390527 · USpolyneuropathy

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗